Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
René-Olivier CasasnovasReda BouabdallahPauline BriceJulien LazaroviciHervé GhesquieresAspassia StamatoullasJehan DupuisAnne-Claire GacThomas GastinneBertrand JolyKrimo BouabdallahEmmanuelle Nicolas-VirelizierPierre FeugierJudith TrotmanDavid SibonChristophe BonnetAlina Berriolo-RiedingerVéronique EdelineMarie ParrensDiane DamotteDiane CosoMarc AndréMichel MeignanCédric RossiPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
The extended follow-up confirms the continued efficacy and favorable safety of AHL2011 PET-driven strategy, which is noninferior to standard six cycles of BEACOPP. PET4 provides additional prognostic information to PET2 and allows identifying patients with particularly poor prognosis.